Protective Role of Intermittent Fasting and Probiotics on Inflammatory bowel diseases

Abstract

Inflammatory Bowel Diseases (IBD) which include Crohn’s disease and ulcerative colitis are chronic, relapsing-remitting inflammatory disorders of the gastrointestinal tract. While their precise etiology is multifactorial implicating genetic susceptibility, immune dysregulation, microbiota imbalance, and environmental triggers—emerging non-pharmacological interventions such as intermittent fasting (IF) and probiotic supplementation have shown promise in modulating disease activity and gut homeostasis.